Archived Grant Opportunity View - GO5543

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

• Stream 1: develop, implement and/or validate therapeutic approaches (drug and/or non-drug) for improving the management of pain and symptoms in individuals with pancreatic cancer
• Stream 2: promote Australian involvement in international collaborative investigator-initiated clinical trials testing the effectiveness of treatments (drug and/or non-drug) for pancreatic cancer through the establishment and coordination of clinical trials site/s in Australia.

Applications to this grant opportunity must propose research that addresses one of the two Streams of research. An application may only be submitted to one of the above two Streams only.

Applications will only be accepted from NHMRC approved Eligible Organisations. A list of NHMRC approved Organisations is available on GrantConnect and on the NHMRC website:

https://www.nhmrc.gov.au/funding/manage-your-funding/mrff-eligible-organisations

Applications must satisfy all the requirements set out in section 1.2 of the MRFF 2022 Pancreatic Cancer Research grant opportunity guidelines.

$12,000,000.00

From $0.00 to $2,000,000.00

Applicants are advised to read the Grant Guidelines thoroughly and liaise with the Eligible Organisations that will submit the application to identify any specific requirements that the Organisation might have.

Applications must be submitted electronically using the NHMRC’s online grants system (Sapphire).

Minimum Data Date:

• Stream 1 – 24 August 2022
• Stream 2 – 23 November 2022